secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001140361-25-026431
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys receives Nasdaq minimum bid price non-compliance notice; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq notified Femasys on July 16, 2025, of non-compliance with $1.00 minimum bid price for 30 consecutive business days.
- Company has until January 12, 2026, to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not cured, Femasys may qualify for an additional 180-day period if it meets other initial listing standards.
- Management may consider a reverse stock split to cure the deficiency; no immediate impact on trading.
- Failure to regain compliance could lead to delisting; the company can appeal any delisting determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125026431/0001140361-25-026431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125026431/ef20052211_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-026431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer